175205-27-3

Usage

Physical appearance

Yellow crystalline powder

Uses

Synthesis of pharmaceutical intermediates and organic compounds

Potential applications

Medicinal chemistry, drug discovery

Other uses

Research and development in laboratories

Properties

Unique chemical properties and reactivity

Handling precautions

Careful handling and storage procedures recommended due to its complex structure and potential reactivity.

Upstream product

• 38861-78-8 1-(4-isobutyl-phenyl)-ethanone 
• 104-88-1 4-chlorobenzaldehyde 

Downstream Products

• 1374882-34-4 4-(4-chlorophenyl)-4,5-dihydro-6-(4-isobutylphenyl)-2H-indazol-3-ol 
• 1393937-34-2 C₂₅H₂₇ClO₃ 

Relevant academic research and scientific papers

Synthesis and anti-inflammatory evaluation of new 1,3,5-triaryl-4,5-dihydro-1H-pyrazole derivatives possessing an aminosulphonyl pharmacophore

A novel series of 2-pyrazoline derivatives 13a-l was synthesized via aldol condensation of 4-substituted acetophenones with appropriately substituted aldehydes followed by cyclization of the formed chalcones with 4-hydrazinobenzenesulfonamide hydrochlorid

Synthesis and antimicrobial activities of new 4,6-diaryl- 4,5-dihydro-3-hydroxy-2H-indazoles

A series of new 4,6-diaryl-4,5-dihydro-3-hydroxy-2H-indazoles 5a-5k were synthesized by the cyclization of ethyl 2-oxo-4,6-diarylcyclohex-3-ene carboxylates 4a-4k. The compounds were characterized by IR, 1H NMR, 13C NMR, 2D NMR, and elemental analysis. The synthesized compounds were evaluated for in vitro antibacterial and antifungal activities against Staphylococcus aureus, Escherichia coli, Salmonella typhimurium, Pseudomonas aeruginosa, Candida albicans, Aspergillus niger, Aspergillus flavus, and Rhizopus sp. Most of the compounds exhibited good activity against the tested organisms. Copyright